Skip to content

Prospective study on the effectiveness assessment of Indocyanine Green Lymphography, MR lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.

Prospective study on the effectiveness assessment of Indocyanine Green Lymphography, MR lymphography and Lymphatic Surgery for lymphedema and lymphatic disease. - Prospective study of Lymphatic surgery (Joint research of 2 hospitals).

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017855
Enrollment
50
Registered
2015-06-10
Start date
2015-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema and lymphatic disease

Interventions

Indocyanine green (ICG) lymphography, MR lymphography and Lymphatic surgery

Sponsors

Tokyo Takanawa Hospital, Nadogaya Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All Subjects included in this study are lymphedema and lymphatic disease patients undergoing surgical treatment at 2 hospitals (Tokyo Takanawa Hospital and Nadogaya Hospital) who have been fully informed of all clinical tests, questionnaires, surgical treatments, and the purpose and analysis of this study and have all consented in writing. No age restriction and exclusion criteria were set.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Patient chart (name, patient ID, clinical history, pre and postoperative course, limb circumference, tissue stiffness); echogram, CT, MRI, MR lymphography, lymphoscintigraphy, indocyanine green lymphography, and lymphoangiography obervations; blood test (complete blood count, chemistry, coagulation, blood type); histopathological analysis (collecting lymphatic vessel, adipose tissue, skin tissue, etc.); clinical photography (bilateral upper limbs for upper limb edema, bilateral lower limbs, abdominal, and inguinal area for lower limb lymphedema); health-related QOL analysis using Short Form (SF)-36 Health Survey; patient weight; general physical and image observations.

Countries

Japan

Contacts

Public Contactshusei

Tokyo Takanawa Hospital somu

mihara-m@saiseikai.gr.jp03-3443-9191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026